Steven G. Potkin | Psychiatrist.com

Original Research

Applicability of a Genetic Signature for Enhanced Iloperidone Efficacy in the Treatment of Schizophrenia

Article

Asenapine: A Clinical Overview

Academic Highlights

Challenges and Solutions in Developing New Medications for Schizophrenia

Commentary

Treatment-Resistant Schizophrenia Guideline

Read expert commentary on guidelines for treatment-resistant schizophrenia (TRS) to make more informed treatment decisions.

Original Research

A Double-Blind, Randomized Study Comparing the Efficacy and Safety of Sertindole and Risperidone in Patients With Treatment-Resistant Schizophrenia

Original Research

Effectiveness of Switching to Ziprasidone for Stable but Symptomatic Outpatients With Schizophrenia

Original Research

Olanzapine/Samidorphan for Schizophrenia

Read a study evaluating the antipsychotic efficacy and safety of OLZ/SAM compared with placebo in patients with an acute exacerbation of schizophrenia.

Original Research

Efficacy and Tolerability of Asenapine in Acute Schizophrenia: A Placebo- and Risperidone-Controlled Trial

Original Research

Long-Term Remission With Cariprazine in Patients With Schizophrenia

When treating patients with schizophrenia, achieving stable, long-term remission is an important step toward the goal of functional recovery. This study evaluated the effect of cariprazine on several measures...

Original Research

Ziprasidone in Treatment-Resistant Schizophrenia: A 52-Week, Open-Label Continuation Study

Letter to the Editor

Reply to Allergic Reactions and Sudden Death with Asenapine